SWOG Stories

Dr. James Wade, III and Mindy Whisnant
NCORP investigators enroll more than a third of patients to SWOG trials
Heidi Adams and Dr. Lara Davis
Nov 2, 2017
By 2040, the number of U.S. cancer survivors is predicted to nearly double to 26.1 million
Karen Anderson and Sandra Hamilton, RN, BSH, MEd
Nov 2, 2017
SELECT is one of the most diverse U.S. cancer prevention trials ever completed
Jill Hamilton-Reeves, PhD & Joshua Mammen, MD, PhD
Oct 31, 2017
Nearly 100 young investigators have received research and training support from SWOG